Impact of dietary fibers on nutrient management and detoxification organs: Gut, liver, and kidneys

Advances in Nutrition

Volumn 7, Issue 6, 2016, Pages 1111-1121

  Kieffer, Dorothy A ^a,b   Martin, Roy J ^a,b   Adams, Sean H ^a,c,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b AGRICULTURAL RESEARCH SERVICE   (United States)

^c U S DEPARTMENT OF AGRICULTURE   (United States)

^d UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

Chronic kidney disease; Fiber; Microbiota; Nonalcoholic fatty liver disease; Xenobiotic

Indexed keywords

DIET; DIETARY FIBER; DRUG EFFECTS; GASTROINTESTINAL TRACT; HUMAN; INFLAMMATION; INTESTINE FLORA; KIDNEY; LIVER; METABOLISM; MICROBIOLOGY; PATHOLOGY; PHARMACOLOGY;

DIET; DIETARY FIBER; GASTROINTESTINAL MICROBIOME; GASTROINTESTINAL TRACT; HUMANS; INFLAMMATION; KIDNEY; LIVER;

EID: 84997498807     PISSN: 21618313     EISSN: 21565376     Source Type: Journal    
DOI: 10.3945/an.116.013219     Document Type: Review

References (159)

1. Burkitt DP. Colonic-rectal cancer: fiber and other dietary factors. Am J Clin Nutr 1978;31(Suppl):S58-64.
2. Johnston KL, Thomas EL, Bell JD, Frost GS, Robertson MD. Resistant starch improves insulin sensitivity in metabolic syndrome. Diabet Med 2010;27:391-7.
3. Threapleton DE, Greenwood DC, Evans CEL, Cleghorn CL, Nykjaer C, Woodhead C, Cade JE, Gale CP, Burley VJ. Dietary fibre intake and risk of cardiovascular disease: systematic review and meta-analysis. BMJ 2013;347.
4. Parnell JA, Raman M, Rioux KP, Reimer RA. The potential role of prebiotic fibre for treatment and management of non-alcoholic fatty liver disease and associated obesity and insulin resistance. Liver Int 2012; 32:701-11.
5. Bliss DZ, Stein TP, Schleifer CR, Settle RG. Supplementation with gum arabic fiber increases fecal nitrogen excretion and lowers serum urea nitrogen concentration in chronic renal failure patients consuming a low-protein diet. Am J Clin Nutr 1996;63:392-8.
6. Roberfroid M. Dietary fiber, inulin, and oligofructose: a review comparing their physiological effects. Crit Rev Food Sci Nutr 1993;33: 103-48.
7. Slavin J. Fiber and prebiotics: mechanisms and health benefits. Nutrients 2013;5:1417-35.
8. Vahouny GV, Kritchevsky D. Dietary fiber in health and disease. New York: Springer Science & Business Media; 2013.
9. Ze X, Duncan SH, Louis P, Flint HJ. Ruminococcus bromii is a keystone species for the degradation of resistant starch in the human colon. ISME J 2012;6:1535-43.
10. Zhou J, Martin RJ, Tulley RT, Raggio AM, McCutcheon KL, Shen L, Danna SC, Tripathy S, Hegsted M, Keenan MJ. Dietary resistant starch upregulates total GLP-1 and PYY in a sustained day-long manner through fermentation in rodents. Am J Physiol Endocrinol Metab 2008;295:E1160-6.
11. Aliasgharzadeh A, Dehghan P, Gargari BP, Asghari-Jafarabadi M. Resistant dextrin, as a prebiotic, improves insulin resistance and inflammation in women with type 2 diabetes: a randomised controlled clinical trial. Br J Nutr 2015;113:321-30.
12. David LA, Maurice CF, Carmody RN, Gootenberg DB, Button JE, Wolfe BE, Ling AV, Devlin AS, Varma Y, Fischbach MA, et al. Diet rapidly and reproducibly alters the human gut microbiome. Nature 2014; 505:559-63.
13. Compare D, Coccoli P, Rocco A, Nardone O, De Maria S, Cartenì M, Nardone G. Gut-liver axis: the impact of gut microbiota on non alcoholic fatty liver disease. Nutr Metab Cardiovasc Dis 2012;22:471-6.
14. Rossi M, Johnson DW, Campbell KL. The kidney-gut axis: implications for nutrition care. J Ren Nutr 2015;25:399-403.
15. Turner ND, Lupton JR. Dietary fiber. Adv Nutr 2011;2:151-2.
16. Institute of Medicine. Dietary Reference Intakes for energy, carbohydrate, fiber, fat, fatty acids, cholesterol, protein, and amino acids. Washington (DC): Institute of Medicine; 2002.
17. Dikeman CL, Fahey GC. Viscosity as related to dietary fiber: a review. Crit Rev Food Sci Nutr 2006;46:649-63.
18. Bliss DZ, Weimer PJ, Jung H-JG, Savik K. In vitro degradation and fermentation of three dietary fiber sources by human colonic bacteria. J Agric Food Chem 2013;61:4614-21.
19. DeVries J, Prosky L, Li B, Cho S. A historical perspective on defining dietary fiber. Cereal Foods World 1999;44:367-9.
20. Lattimer JM, Haub MD. Effects of dietary fiber and its components on metabolic health. Nutrients 2010;2:1266-89.
21. Hatakeyama H, Hatakeyama T. Lignin structure, properties, and applications. In: Abe A, Dusek K, Kobayashi S, editors. Biopolymers: lignin, proteins, bioactive nanocomposites. Berlin, Heidelberg (Germany): Springer Berlin Heidelberg; 2010. p. 1-63.
22. O'Sullivan AC. Cellulose: the structure slowly unravels. Cellulose 1997;4:173-207.
23. Izydorczyk MS, Biliaderis CG. Cereal arabinoxylans: advances in structure and physicochemical properties. Carbohydr Polym 1995; 28:33-48.
24. Mensink MA, Frijlink HW, van der Voort Maarschalk K, Hinrichs WLJ. Inulin, a flexible oligosaccharide I: review of its physicochemical characteristics. Carbohydr Polym 2015;130:405-19.
25. Moshfegh AJ, Friday JE, Goldman JP, Ahuja JKC. Presence of inulin and oligofructose in the diets of Americans. J Nutr 1999;129(Suppl): 1407S-11S.
26. Izydorczyk M, Dexter J. Barley b-glucans and arabinoxylans: molecular structure, physicochemical properties, and uses in food products-a review. Food Res Int 2008;41:850-68.
27. Mudgil D, Barak S, Khatkar BS. Guar gum: processing, properties and food applications-a review. J Food Sci Technol 2014;51:409-18.
28. Nussinovitch A. Plant gum exudates of the world: sources, distribution, properties, and applications. Boca Raton (FL): CRC Press; 2009.
29. Mohnen D. Pectin structure and biosynthesis. Curr Opin Plant Biol 2008;11:266-77.
30. Marlett JA. Content and composition of dietary fiber in 117 frequently consumed foods. J Am Diet Assoc 1992;92:175-86.
31. Fischer MH, Yu N, Gray GR, Ralph J, Anderson L, Marlett JA. The gel-forming polysaccharide of psyllium husk (Plantago ovata Forsk). Carbohydr Res 2004;339:2009-17.
32. Crittenden R, Playne MJ. Production, properties and applications of food-grade oligosaccharides. Trends Food Sci Technol 1996;7:353-61.
33. IUB-IUPAC Joint Commission on Biochemical Nomenclature (JCBN). Abbreviated terminology of oligosaccharide chains: recommendations 1980. J Biol Chem 1982;257:3347-51.
34. Birt DF, Boylston T, Hendrich S, Jane J-L, Hollis J, Li L, McClelland J, Moore S, Phillips GJ, Rowling M. Resistant starch: promise for improving human health. Adv Nutr 2013;4:587-601.
35. Keenan MJ, Zhou J, Hegsted M, Pelkman C, Durham HA, Coulon DB, Martin RJ. Role of resistant starch in improving gut health, adiposity, and insulin resistance. Adv Nutr 2015;6:198-205.
36. Underhill DM, Iliev ID. The mycobiota: interactions between commensal fungi and the host immune system. Nat Rev Immunol 2014; 14:405-16.
37. Cadwell K. Expanding the role of the virome: commensalism in the gut. J Virol 2015;89:1951-3.
38. Gill SR, Pop M, DeBoy RT, Eckburg PB, Turnbaugh PJ, Samuel BS, Gordon JI, Relman DA, Fraser-Liggett CM, Nelson KE. Metagenomic analysis of the human distal gut microbiome. Science 2006;312:1355-9.
39. Qin J, Li R, Raes J, ArumugamM, Burgdorf KS, Manichanh C, Nielsen T, Pons N, Levenez F, Yamada T, et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature 2010;464 (7285):59-65. [cited 2016 Jan 21]. Available from: http://www. nature.com/nature/journal/v464/n7285/suppinfo/nature08821_S1.html.
40. Koropatkin NM, Cameron EA, Martens EC. How glycan metabolism shapes the human gut microbiota. Nat Rev Microbiol 2012;10:323-35.
41. Carding S, Verbeke K, Vipond DT, Corfe BM, Owen L. Dysbiosis of the gut microbiota in disease. Microbial ecology in health and disease 2015;26:1-9.
42. O'Sullivan O, Cronin O, Clarke SF, Murphy EF, Molloy MG, Shanahan F, Cotter PD. Exercise and the microbiota. Gut Microbes 2015;6:131-6.
43. Bailey MT, Dowd SE, Galley JD, Hufnagle AR, Allen RG, Lyte M. Exposure to a social stressor alters the structure of the intestinal microbiota: implications for stressor-induced immunomodulation. Brain Behav Immun 2011;25:397-407.
44. Zhang L, Nichols RG, Correll J, Murray IA, Tanaka N, Smith P, Hubbard TD, Sebastian A, Albert I, Hatzakis E. Persistent organic pollutants modify gut microbiota-host metabolic homeostasis in mice through aryl hydrocarbon receptor activation. Environmental Health Perspectives 2015;123(7):679-88.
45. Turnbaugh PJ, Gordon JI. The core gut microbiome, energy balance and obesity. J Physiol 2009;587:4153-8.
46. Chung WSF, Walker AW, Louis P, Parkhill J, Vermeiren J, Bosscher D, Duncan SH, Flint HJ. Modulation of the human gut microbiota by dietary fibres occurs at the species level. BMC Biol 2016;14:3-13.
47. Voragen AG, Coenen G-J, Verhoef RP, Schols HA. Pectin, a versatile polysaccharide present in plant cell walls. Struct Chem 2009;20: 263-75.
48. Umu öC, Frank JA, Fangel JU, Oostindjer M, da Silva CS, Bolhuis EJ, Bosch G, Willats WG, Pope PB, Diep DB. Resistant starch diet induces change in the swine microbiome and a predominance of beneficial bacterial populations. Microbiome 2015;3:16.
49. Annison G, Topping DL. Nutritional role of resistant starch: chemical structure vs physiological function. Annu Rev Nutr 1994;14:297-320.
50. De Filippo C, Cavalieri D, Di Paola M, Ramazzotti M, Poullet JB, Massart S, Collini S, Pieraccini G, Lionetti P. Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa. Proc Natl Acad Sci USA 2010;107:14691-6.
51. Hamaker BR, Tuncil YE. A perspective on the complexity of dietary fiber structures and their potential effect on the gut microbiota. J Mol Biol 2014;426:3838-50.
52. Claesson MJ, Jeffery IB, Conde S, Power SE, O'Connor EM, Cusack S, Harris HM, Coakley M, Lakshminarayanan B, O'Sullivan O, et al. Gut microbiota composition correlates with diet and health in the elderly. Nature 2012;488:178-84.
53. Frank DN, St Amand AL, Feldman RA, Boedeker EC, Harpaz N, Pace NR. Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc Natl Acad Sci USA 2007;104:13780-5.
54. Lozupone CA, Stombaugh JI, Gordon JI, Jansson JK, Knight R. Diversity, stability and resilience of the human gut microbiota. Nature 2012; 489:220-30.
55. Macfarlane GT, Macfarlane S. Human colonic microbiota: ecology, physiology and metabolic potential of intestinal bacteria. Scand J Gastroenterol Suppl 1997;222:3-9.
56. Sonnenburg ED, Smits SA, Tikhonov M, Higginbottom SK, Wingreen NS, Sonnenburg JL. Diet-induced extinctions in the gut microbiota compound over generations. Nature 2016;529:212-5.
57. Cordain L, Eaton SB, Sebastian A, Mann N, Lindeberg S, Watkins BA, O'Keefe JH, Brand-Miller J. Origins and evolution of the Western diet: health implications for the 21st century. Am J Clin Nutr 2005;81:341-54.
58. Satchithanandam S, Vargofcak-Apker M, Calvert RJ, Leeds AR, Cassidy MM. Alteration of gastrointestinal mucin by fiber feeding in rats. J Nutr 1990;120:1179-84.
59. Piel C, Montagne L, Sève B, Lallès J-P. Increasing digesta viscosity using carboxymethylcellulose in weaned piglets stimulates ileal goblet cell numbers and maturation. J Nutr 2005;135:86-91.
60. Lamont JT. Mucus: the front line of intestinal mucosal defense. Ann N Y Acad Sci 1992;664:190-201.
61. Earle KA, Billings G, Sigal M, Lichtman JS, Hansson GC, Elias JE, Amieva MR, Huang KC, Sonnenburg JL. Quantitative imaging of gut microbiota spatial organization. Cell Host Microbe 2015;18(4): 478-88.
62. Goodlad RA, Ratcliffe B, Fordham JP, Wright NA. Does dietary fibre stimulate intestinal epithelial cell proliferation in germ free rats? Gut 1989;30:820-5.
63. Sun Y, O'Riordan MXD. Regulation of bacterial pathogenesis by intestinal short-chain fatty acids. Adv Appl Microbiol 2013;85:93-118.
64. Kelly CJ, Zheng L, Campbell Eric L, Saeedi B, Scholz Carsten C, Bayless Amanda J, Wilson Kelly E, Glover Louise E, Kominsky Douglas J, Magnuson A, et al. Crosstalk between microbiota-derived short-chain fatty acids and intestinal epithelial HIF augments tissue barrier function. Cell Host Microbe 2015;17:662-71.
65. Karhausen J, Furuta GT, Tomaszewski JE, Johnson RS, Colgan SP, Haase VH. Epithelial hypoxia-inducible factor-1 is protective in murine experimental colitis. J Clin Invest 2004;114:1098-106.
66. Tambuwala MM, Cummins EP, Lenihan CR, Kiss J, Stauch M, Scholz CC, Fraisl P, Lasitschka F, Mollenhauer M, Saunders SP. Loss of prolyl hydroxylase-1 protects against colitis through reduced epithelial cell apoptosis and increased barrier function. Gastroenterology 2010; 139:2093-101.
67. Keenan MJ, Martin RJ, Raggio AM, McCutcheon KL, Brown IL, Birkett A, Newman SS, Skaf J, Hegsted M, Tulley RT, et al. A microarray study indicates high-amylose resistant starch increases hormones and improves structure and function of the GI tract. J Nutrigenet Nutrigenomics 2012;5:26-44.
68. Cani PD, Possemiers S, Van de Wiele T, Guiot Y, Everard A, Rottier O, Geurts L, Naslain D, Neyrinck A, Lambert DM, et al. Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability. Gut 2009; 58:1091-103.
69. Benjamin MA, McKay DM, Yang P-C, Cameron H, Perdue MH. Glucagon-like peptide-2 enhances intestinal epithelial barrier function of both transcellular and paracellular pathways in the mouse. Gut 2000; 47:112-9.
70. Hadjiyanni I, Li KK, Drucker DJ. Glucagon-like peptide-2 reduces intestinal permeability but does not modify the onset of type 1 diabetes in the nonobese diabetic mouse. Endocrinology 2009;150:592-9.
71. Jasleen J, Ashley SW, Shimoda N, Zinner MJ, Whang EE. Glucagonlike peptide 2 stimulates intestinal epithelial proliferation in vitro. Dig Dis Sci 2002;47:1135-40.
72. Bulut K, Meier JJ, Ansorge N, Felderbauer P, Schmitz F, Hoffmann P, Schmidt WE, Gallwitz B. Glucagon-like peptide 2 improves intestinal wound healing through induction of epithelial cell migration in vitro-evidence for a TGF-b-mediated effect. Regul Pept 2004;121:137-43.
73. Fukunaga T, Sasaki M, Araki Y, Okamoto T, Yasuoka T, Tsujikawa T, Fujiyama Y, Bamba T. Effects of the soluble fibre pectin on intestinal cell proliferation, fecal short chain fatty acid production and microbial population. Digestion 2003;67(1-2):42-9.
74. Peng L, Li Z-R, Green RS, Holzman IR, Lin J. Butyrate enhances the intestinal barrier by facilitating tight junction assembly via activation of AMP-activated protein kinase in Caco-2 cell monolayers. J Nutr 2009;139:1619-25.
75. Ohata A, Usami M, Miyoshi M. Short-chain fatty acids alter tight junction permeability in intestinal monolayer cells via lipoxygenase activation. Nutrition 2005;21:838-47.
76. Mosenthal AC, Xu D, Deitch EA. Elemental and intravenous total parenteral nutrition diet-induced gut barrier failure is intestinal site specific and can be prevented by feeding nonfermentable fiber. Crit Care Med 2002;30:396-402.
77. Koruda MJ, Rolandelli RH, Settle RG, Zimmaro DM, Rombeau JL. Effect of parenteral nutrition supplemented with short-chain fatty acids on adaptation to massive small bowel resection. Gastroenterology 1988;95:715-20.
78. Alverdy JC. Effects of glutamine-supplemented diets on immunology of the gut. JPEN J Parenter Enteral Nutr 1990;14(4, Suppl):109S-13S.
79. Castro GA, Arntzen CJ. Immunophysiology of the gut: a research frontier for integrative studies of the common mucosal immune system. Am J Physiol 1993;265:G599-610.
80. Alisi A, Ceccarelli S, Panera N, Nobili V. Causative role of gut microbiota in non-alcoholic fatty liver disease pathogenesis. Front Cell Infect Microbiol 2012;2:132.
81. Brun P, Castagliuolo I, Leo VD, Buda A, Pinzani M, Palù G, Martines D. Increased intestinal permeability in obese mice: new evidence in the pathogenesis of nonalcoholic steatohepatitis. Am J Physiol Gastrointest Liver Physiol 2007;292:G518-25.
82. Lau WL, Kalantar-Zadeh K, Vaziri ND. The gut as a source of inflammation in chronic kidney disease. Nephron 2015;130:92-8.
83. Bornet FR, Brouns F. Immune-stimulating and gut health-promoting properties of short-chain fructo-oligosaccharides. Nutr Rev 2002;60 (10, Part 1):326-34.
84. Zhang S, Li W, Smith CJ, Musa H. Cereal-derived arabinoxylans as biological response modifiers: extraction, molecular features, and immunestimulating properties. Crit Rev Food Sci Nutr 2015;55:1035-52.
85. Volman JJ, Ramakers JD, Plat J. Dietary modulation of immune function by b-glucans. Physiol Behav 2008;94:276-84.
86. Ito H, Takemura N, Sonoyama K, Kawagishi H, Topping DL, Conlon MA, Morita T. Degree of polymerization of inulin-type fructans differentially affects number of lactic acid bacteria, intestinal immune functions, and immunoglobulin A secretion in the rat cecum. J Agric Food Chem 2011;59:5771-8.
87. Jenkins DJ, Wolever TM, Leeds AR, Gassull MA, Haisman P, Dilawari J, Goff DV, Metz GL, Alberti KG. Dietary fibres, fibre analogues, and glucose tolerance: importance of viscosity. BMJ 1978;1:1392-4.
88. Kagnoff MF. Immunology of the intestinal tract. Gastroenterology 1993;105:1275-80.
89. Smith PM, Howitt MR, Panikov N, Michaud M, Gallini CA, Bohlooly YM, Glickman JN, Garrett WS. The microbial metabolites, shortchain fatty acids, regulate colonic Treg cell homeostasis. Science 2013;341:569-73.
90. Smith PM, Howitt MR, Panikov N, Michaud M, Gallini CA, Bohlooly-Y M, Glickman JN, Garrett WS. The microbial metabolites, short chain fatty acids, regulate colonic Treg cell homeostasis. Science 2013;341(6145):569-73.
91. Brown K, DeCoffe D, Molcan E, Gibson DL. Diet-induced dysbiosis of the intestinal microbiota and the effects on immunity and disease. Nutrients 2012;4:1095-119.
92. Mithieux G, Andreelli F, Magnan C. Intestinal gluconeogenesis: key signal of central control of energy and glucose homeostasis. Curr Opin Clin Nutr Metab Care 2009;12:419-23.
93. De Vadder F, Kovatcheva-Datchary P, Goncalves D, Vinera J, Zitoun C, Duchampt A, Bäckhed F, Mithieux G. Microbiota-generated metabolites promote metabolic benefits via gut-brain neural circuits. Cell 2013;156(1):84-96.
94. Bugianesi E, Marzocchi R, Villanova N, Marchesini G. Non-alcoholic fatty liver disease/non-alcoholic steatohepatitis (NAFLD/NASH): treatment. Best Pract Res Clin Gastroenterol 2004;18:1105-16.
95. Takino J-i, Nagamine K, Hori T, Sakasai-Sakai A, Takeuchi M. Contribution of the toxic advanced glycation end-products-receptor axis in nonalcoholic steatohepatitis-related hepatocellular carcinoma. World J Hepatol 2015;7:2459-69.
96. Kraut JA, Kurtz I. Metabolic acidosis of CKD: diagnosis, clinical characteristics, and treatment. Am J Kidney Dis 2005;45:978-93.
97. Stinghen AEM, Massy ZA, Vlassara H, Striker GE, Boullier A. Uremic toxicity of advanced glycation end products in CKD. J Am Soc Nephrol 2016;27:354-70.
98. Parnell JA, Raman M, Rioux KP, Reimer RA. The potential role of prebiotic fibre for treatment and management of non-alcoholic fatty liver disease and associated obesity and insulin resistance. Liver Int 2012;32 (5):701-11.
99. Miele L, Valenza V, La Torre G, Montalto M, Cammarota G, Ricci R, Masciana R, Forgione A, Gabrieli ML, Perotti G, et al. Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease. Hepatology 2009;49:1877-87.
100. Such J, Francés R, Muñoz C, Zapater P, Casellas JA, Cifuentes A, Rodríguez-Valera F, Pascual S, Sola-Vera J, Carnicer F. Detection and identification of bacterial DNA in patients with cirrhosis and culturenegative, nonneutrocytic ascites. Hepatology 2002;36:135-41.
101. Sugihara T, Koda M, Maeda Y, Matono T, Nagahara T, Mandai M, Ueki M, Murawaki Y. Rapid identification of bacterial species with bacterial DNA microarray in cirrhotic patients with spontaneous bacterial peritonitis. Intern Med 2009;48:3-10.
102. Lecerf JM, Depeint F, Clerc E, Dugenet Y, Niamba CN, Rhazi L, Cayzeele A, Abdelnour G, JarugaA, Younes H, et al. Xylo-oligosaccharide (XOS) in combination with inulin modulates both the intestinal environment and immune status in healthy subjects, while XOS alone only shows prebiotic properties. Br J Nutr 2012;108:1847-58.
103. Paschos P, Paletas K. Non alcoholic fatty liver disease two-hit process: multifactorial character of the second hit. Hippokratia 2009; 13:128.
104. Ban SJ, Rico CW, Um IC, Kang MY. Antihyperglycemic and antioxidative effects of hydroxyethyl methylcellulose (HEMC) and hydroxypropyl methylcellulose (HPMC) in mice fed with a high fat diet. Int J Mol Sci 2012;13:3738-50.
105. Nugon-Baudon L, Roland N, Flinois J-P, Beaune P. Hepatic cytochrome P450 and UDP-glucuronosyl transferase are affected by five sources of dietary fiber in germ-free rats. J Nutr 1996;126: 403-9.
106. Merrell MD, Cherrington NJ. Drug metabolism alterations in nonalcoholic fatty liver disease. Drug Metab Rev 2011;43:317-34.
107. de Haen P. Recent progress in pharmacological studies on bile acids. J Am Pharm Assoc 1944;33:161-9.
108. Makishima M, Okamoto AY, Repa JJ, Tu H, Learned RM, Luk A, Hull MV, Lustig KD, Mangelsdorf DJ, Shan B. Identification of a nuclear receptor for bile acids. Science 1999;284:1362-5.
109. Ridlon JM, Kang D-J, Hylemon PB. Bile salt biotransformations by human intestinal bacteria. J Lipid Res 2006;47:241-59.
110. Eyssen H, Van Eldere J, Parmentier G, Huijghebaert S, Mertens J. Influence of microbial bile salt desulfation upon the fecal excretion of bile salts in gnotobiotic rats. J Steroid Biochem 1985;22:547-54.
111. Gérard P. Metabolism of cholesterol and bile acids by the gut microbiota. Pathogens 2013;3:14.
112. Kakiyama G, Pandak WM, Gillevet PM, Hylemon PB, Heuman DM, Daita K, Takei H, Muto A, Nittono H, Ridlon JM, et al. Modulation of the fecal bile acid profile by gut microbiota in cirrhosis. J Hepatol 2013;58:949-55.
113. Ridlon JM, Alves JM, Hylemon PB, Bajaj JS. Cirrhosis, bile acids and gut microbiota: Unraveling a complex relationship. GutMicrobes 2013;4:382-7.
114. Li Y, Jadhav K, Zhang Y. Bile acid receptors in non-alcoholic fatty liver disease. Biochem Pharmacol 2013;86:1517-24.
115. Yang ZX, Shen W, Sun H. Effects of nuclear receptor FXR on the regulation of liver lipid metabolism in patients with non-alcoholic fatty liver disease. Hepatol Int 2010;4:741-8.
116. Sayin SI, Wahlstrom A, Felin J, Jantti S, Marschall HU, Bamberg K, Angelin B, Hyotylainen T, Oresic M, Backhed F. Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist. Cell Metab 2013;17:225-35.
117. Vahouny GV, Khalafi R, Satchithanandam S, Watkins DW, Story JA, Cassidy MM, Kritchevsky D. Dietary fiber supplementation and fecal bile acids, neutral steroids and divalent cations in rats. J Nutr 1987; 117:2009-15.
118. Alberts DS, Einspahr JG, Earnest DL, Krutzsch MF, Lin P, Hess LM, Heddens DK, Roe DJ, Martínez ME, Salen G, et al. Fecal bile acid concentrations in a subpopulation of the Wheat Bran Fiber Colon Polyp Trial. Cancer Epidemiol Biomarkers Prev 2003;12:197-200.
119. Mafra D, Fouque D. Gut microbiota and inflammation in chronic kidney disease patients. Clin Kidney J 2015;8:332-4.
120. Vaziri ND, Wong J, Pahl M, Piceno YM, Yuan J, DeSantis TZ, Ni Z, Nguyen TH, Andersen GL. Chronic kidney disease alters intestinal microbial flora. Kidney Int 2013;83:308-15.
121. Wang F, Jiang H, Shi K, Ren YI, Zhang PAN, Cheng S. Gut bacterial translocation is associated with microinflammation in end-stage renal disease patients. Nephrology (Carlton) 2012;17:733-8.
122. Zuckerman GR, Cornette GL, Clouse RE, Harter HR. Upper gastrointestinal bleeding in patients with chronic renal failure. Ann Intern Med 1985;102:588-92.
123. Margolis DM, Saylor JL, Geisse G, DeSchryver-Kecskemeti K, Harter HR, Zuckerman GR. Upper gastrointestinal disease in chronic renal failure: a prospective evaluation. Arch Intern Med 1978;138:1214-7.
124. Wu I-W, Hsu K-H, Lee C-C, Sun C-Y, Hsu H-J, Tsai C-J, Tzen C-Y, Wang Y-C, Lin C-Y, Wu M-S. p-Cresyl sulphate and indoxyl sulphate predict progression of chronic kidney disease. Nephrol Dial Transplant 2011;26:938-47.
125. Krishnamurthy VMR, Wei G, Baird BC, Murtaugh M, Chonchol MB, Raphael KL, Greene T, Beddhu S. High dietary fiber intake is associated with decreased inflammation and all-cause mortality in patients with chronic kidney disease. Kidney Int 2012;81:300-6.
126. Rossi M, Johnson DW, Xu H, Carrero JJ, Pascoe E, French C, Campbell KL. Dietary protein-fiber ratio associates with circulating levels of indoxyl sulfate and p-cresyl sulfate in chronic kidney disease patients. Nutr Metab Cardiovasc Dis 2015;25(9):860-5.
127. Eknoyan G, Levin A, Levin NW. Bone metabolism and disease in chronic kidney disease. American Journal of Kidney Diseases. 2003; 42(Supp 3):1-201.
128. Sanghavi S, Whiting S, Uribarri J. Potassium balance in dialysis patients. Semin Dial 2013;26:597-603.
129. Wong J, Piceno YM, Desantis TZ, Pahl M, Andersen GL, Vaziri ND. Expansion of urease-and uricase-containing, indole-and p-cresolforming and contraction of short-chain fatty acid-producing intestinal microbiota in ESRD. Am J Nephrol 2014;39:230-7.
130. Bourke E, Milne MD, Stokes GS. Caecal pH and ammonia in experimental uraemia. Gut 1966;7:558-61.
131. Vaziri ND, Yuan J, Rahimi A, Ni Z, Said H, Subramanian VS. Disintegration of colonic epithelial tight junction in uremia: a likely cause of CKD-associated inflammation. Nephrol Dial Transplant 2012;27: 2686-93.
132. Wu I-W, Hsu K-H, Hsu H-J, Lee C-C, Sun C-Y, Tsai C-J, Wu M-S. Serum free p-cresyl sulfate levels predict cardiovascular and all-cause mortality in elderly hemodialysis patients-a prospective cohort study. Nephrol Dial Transplant 2012;27:1169.
133. Barreto FC, Barreto DV, Liabeuf S, Meert N, Glorieux G, Temmar M, Choukroun G, Vanholder R, Massy ZA. Serum indoxyl sulfate is associated with vascular disease and mortality in chronic kidney disease patients. Clin J Am Soc Nephrol 2009;4:1551-8.
134. Sirich TL, Plummer NS, Gardner CD, Hostetter TH, Meyer TW. Effect of increasing dietary fiber on plasma levels of colon-derived solutes in hemodialysis patients. Clin J Am Soc Nephrol 2014;9:1603-10.
135. Vaziri ND, Liu S-M, Lau WL, Khazaeli M, Nazertehrani S, Farzaneh SH, Kieffer DA, Adams SH, Martin RJ. High amylose resistant starch diet ameliorates oxidative stress, inflammation, and progression of chronic kidney disease. PLoS One 2014;9:e114881.
136. Pang KS, Schwab AJ, Goresky CA, Chiba M. Transport, binding, and metabolism of sulfate conjugates in the liver. Chem Biol Interact 1994; 92:179-207.
137. Clayton TA, Baker D, Lindon JC, Everett JR, Nicholson JK. Pharmacometabonomic identification of a significant host-microbiome metabolic interaction affecting human drug metabolism. Proc Natl Acad Sci USA 2009;106:14728-33.
138. Pavan M. Influence of prebiotic and probiotic supplementation on the progression of chronic kidney disease. Minerva Urol Nefrol 2014;68; 222-6.
139. Siddharth M, Datta SK, Bansal S, Mustafa M, Banerjee BD, Kalra OP, Tripathi AK. Study on organochlorine pesticide levels in chronic kidney disease patients: Association with estimated glomerular filtration rate and oxidative stress. J Biochem Mol Toxicol 2012;26:241-7.
140. Younes H, Alphonse J-C, Behr SR, Demigné C, Rémésy C. Role of fermentable carbohydrate supplements with a low-protein diet in the course of chronic renal failure: experimental bases. Am J Kidney Dis 1999;33:633-46.
141. Mardinoglu A, Shoaie S, Bergentall M, Ghaffari P, Zhang C, Larsson E, Backhed F, Nielsen J. The gut microbiota modulates host amino acid and glutathione metabolism in mice. Mol Syst Biol 2015;11:834.
142. Bergen WG. Small-intestinal or colonic microbiota as a potential amino acid source in animals. Amino Acids 2015;47:251-8.
143. Pluznick JL, Protzko RJ, Gevorgyan H, Peterlin Z, Sipos A, Han J, Brunet I, Wan L-X, Rey F, Wang T, et al. Olfactory receptor responding to gut microbiota-derived signals plays a role in renin secretion and blood pressure regulation. Proc Natl Acad Sci USA 2013;110: 4410-5.
144. Remuzzi G, Perico N, Macia M, Ruggenenti P. The role of reninangiotensin-aldosterone system in the progression of chronic kidney disease. Kidney Int Suppl 2005;68:S57-65.
145. Duffy LC, Raiten DJ, Hubbard VS, Starke-Reed P. Progress and challenges in developing metabolic footprints from diet in human gut microbial cometabolism. J Nutr 2015;145(Suppl):1123S-30S.
146. Lange K, Hugenholtz F, Jonathan MC, Schols HA, Kleerebezem M, Smidt H, Müller M, Hooiveld GJEJ. Comparison of the effects of five dietary fibers on mucosal transcriptional profiles, and luminal microbiota composition and SCFA concentrations in murine colon. Mol Nutr Food Res 2015;59:1590-602.
147. Speca S, Dubuquoy L, Desreumaux P. Peroxisome proliferator-activated receptor gamma in the colon: inflammation and innate antimicrobial immunity. J Clin Gastroenterol 2014;48:S23-7.
148. Chang WC, Jia H, Aw W, Saito K, Hasegawa S, Kato H. Beneficial effects of soluble dietary Jerusalem artichoke (Helianthus tuberosus) in the prevention of the onset of type 2 diabetes and non-alcoholic fatty liver disease in high-fructose diet-fed rats. Br J Nutr 2014;112:709-17.
149. Kim H, Bartley GE, Young SA, Seo K-H, Yokoyama W. Altered hepatic gene expression profiles associated with improved fatty liver, insulin resistance, and intestinal permeability after hydroxypropyl methylcellulose (HPMC) supplementation in diet-induced obese mice. J Agric Food Chem 2013;61:6404-11.
150. Kieffer DA, Piccolo BD, Marco ML, Kim EB, Goodson ML, Keenan MJ, Dunn TN, Knudsen KNE, Adams SH, Martin RJ. Obese mice fed a diet supplemented with enzyme-treated wheat bran display marked shifts in the liver metabolome concurrent with altered gut bacteria. J Nutr 2016 Dec (Epub ahead of print); DOI: 10.3945/jn.116.238923).
151. Kieffer DA, Piccolo BD, Marco ML, Kim EB, Goodson ML, Keenan MJ, Dunn TN, Knudsen KEB, Martin RJ, Adams SH. Mice fed a high-fat diet supplemented with resistant starch display marked shifts in the liver metabolome concurrent with altered gut bacteria. J Nutr 2016 Dec (Epub ahead of print); DOI: 10.3945/jn.116.238931).
152. She P, Shiota M, Shelton KD, Chalkley R, Postic C, Magnuson MA. Phosphoenolpyruvate carboxykinase is necessary for the integration of hepatic energy metabolism. Mol Cell Biol 2000;20:6508-17.
153. Zhao YY. Metabolomics in chronic kidney disease. Clin Chim Acta 2013;422:59-69.
154. Zhang Z-H, Wei F, Vaziri ND, Cheng X-L, Bai X, Lin R-C, Zhao Y-Y. Metabolomics insights into chronic kidney disease and modulatory effect of rhubarb against tubulointerstitial fibrosis. Sci Rep 2015;5: 14472.
155. Gerritsen J, Smidt H, Rijkers GT, de Vos WM. Intestinal microbiota in human health and disease: the impact of probiotics. Genes Nutr 2011; 6:209-40.
156. Korpela K, Flint HJ, Johnstone AM, Lappi J, Poutanen K, Dewulf E, Delzenne N, de Vos WM, Salonen A. Gut microbiota signatures predict host and microbiota responses to dietary interventions in obese individuals. PLoS One 2014;9:e90702.
157. King DE, Mainous AG, Lambourne CA. Trends in dietary fiber intake in the United States, 1999-2008. J Acad Nutr Diet 2012;112:642-8.
158. USDA. Scientific report of the 2015 Dietary Guidelines Advisory Committee. Washington (DC): USDA; 2015.
159. Sonnenburg ED, Sonnenburg JL. Starving our microbial self: the deleterious consequences of a diet deficient in microbiota-accessible carbohydrates. Cell Metab 2014;20:779-86.